Nona parte
Bibliografia
1. Acierno MJ, Brown S, Coleman AE, et al. ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med. 2018; vol. 32: pp. 1803-1822.
2. Bartoszuk U, Keene BW, Baron Toaldo M, et al. Holter monitoring demonstrates that ventricular arrhythmias are common in cats with decompensated and compensated hypertrophic cardiomyopathy. Vet J. 2019; vol. 243: pp. 21-25.
3. Bond BR, Fox PR, Peterson ME, et al. Echocardiographic findings in 103 cats with hyperthyroidism. J Am Vet Med Assoc. 1998; vol. 192: pp. 1546-1549.
4. Borgeat K, Niessen SJM, Wilkie L, et al. Time spent with cats is never wasted: Lessons learned from feline acromegalic cardiomyopathy, a naturally occurring animal model of the human disease. PLoS One 2018; vol. 13: p. e0194342.
5. Borgeat K, Wright J, Garrod O, et al. Arterial thromboembolism in 250 cats in general practice: 2004-2012. J Vet Intern Med. 2014; vol. 28: pp. 102-108.
6. Chetboul V1, Passavin P, Trehiou-Sechi E, et al. Clinical, epidemiological and echocardiographic features and prognostic factors in cats with restrictive cardiomyopathy: A retrospective study of 92 cases (2001-2015). J Vet Intern Med. 2019; vol. 33: pp. 1222-1231.
7. Ciaramella P, Basso C, Di Loria A, et al. Arrhythmogenic right ventricular cardiomyopathy associated with severe left ventricular involvement in a cat. J Vet Cardiol. 2009; vol. 11: pp. 41-45.
8. Coté E, MacDonald KA, Montgomery Meurs K, et al. Arrhythmias and other electrocardiographic abnormalities. In: Coté E, MacDonald KA, Montgomery Meurs K, et al. Feline cardiology. 1st Ed., Wiley-Blackwell, Iowa, 2011: pp. 213-253.
9. Coté E, MacDonald KA, Montgomery Meurs K, et al. Arrhythmogenic right ventricular cardiomyopathy. In: Coté E, MacDonald KA, Montgomery Meurs K, et al. Feline cardiology. 1st Ed., Wiley-Blackwell, Iowa, 2011: pp. 189-192.
10. Coté E, MacDonald KA, Montgomery Meurs K, et al. Hypertrophic cardiomyopathy. In: Coté E, MacDonald KA, Montgomery Meurs K, et al. Feline cardiology. 1st Ed., Wiley-Blackwell, Iowa, 2011: pp. 103-175.
11. Elliott P., Andersson B., Arbustini E. et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 2008; vol. 29: pp. 270-276.
12. Ferasin L and De Francesco T. Management of acute heart failure in cats. J Vet Cardiol. 2015; vol. 17S1: pp. 173-189.
13. Ferasin L, Sturgess CP, Cannon MJ, et al. Feline idiopathic cardiomyopathy: a retrospective study of 106 cats (1994-2001). J Feline Med Surg. 2003; vol. 5: pp. 151-159.
14. Fox PR, Basso C, Thiene G, et al. Spontaneously occurring restrictive nonhypertrophied cardiomyopathy in domestic cats: a new animal model of human disease. Cardiovasc Pathol. 2014; vol. 23: pp. 28-34.
15. Fox PR, Keene BW, Lamb K, et al. International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study. J Vet Intern Med. 2018; vol. 32: pp. 930-943.
16. Fox PR, Liu SK, Maron BJ. Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy. An animal model of human disease. Circulation 1995; vol. 1: pp. 2645-51.
17. Fox PR, Maron BJ, Basso C, et al. Spontaneously occurring arrhythmogenic right ventricular cardiomyopathy in the domestic cat: A new animal model similar to the human disease. Circulation 2000; vol. 102: pp. 1863-1870.
18. Guglielmini C and Diana A. Thoracic radiography in the cat: identification of cardiomegaly and congestive heart failure. J Vet Cardiol. 2015; vol. 17S1: pp. 87-101.
19. Häggström J, Luis Fuentes V, Wess G. Screening for hypertrophic cardiomyopathy in cats. J Vet Cardiol. 2015; vol. 17S1: pp. 134-149.
20. Hambrook LE, Bennett PF. Effect of pimobendan on the clinical outcome and survival of cats with non-taurine responsive dilated cardiomyopathy. J Feline Med Surg. 2012; vol. 14: pp. 233-239.
21. Hogan D and Brainard BM. Cardiogenic embolism in the cat. J Vet Cardiol. 2015; vol. 17S1: pp. 202-214.
22. Hogan DF. Feline Cardiogenic Arterial Thromboembolism: Prevention and Therapy. Vet Clin North Am Small Anim Pract. 2017; vol. 47: pp. 1065-1082.
23. Johns SM, Nelson OL, Gay JM. Left atrial function in cats with left-sided cardiac disease and pleural effusion or pulmonary edema. J Vet Intern Med. 2012; vol. 26: pp. 1134-1139.
24. Kimura Y, Karakama S, Hirakawa A, et al. Pathological Features and Pathogenesis of the Endomyocardial Form of Restrictive Cardiomyopathy in Cats. J Comp Pathol. 2016; vol. 155: pp. 190-198.
25. Kittleson MD, Meurs KM, Harris SP. The genetic basis of hypertrophic cardiomyopathy in cats and humans. J Vet Cardiol 2015; vol. 17S1: pp. 53-73.
26. Lamont LA, Bulmer BJ, Sisson DD, et al. Doppler echocardiographic effects of medetomidine on dynamic left ventricular outflow tract obstruction in cats. J Am Vet Med Assoc. 2002; vol. 221: pp. 1276-1281.
27. Locatelli C, Pradelli D, Campo G, et al. Survival and prognostic factors in cats with restrictive cardiomyopathy: a review of 90 cases. J Feline Med Surg. 2018; vol. 20: 1138-1143.
28. Maron B.J., Towbin J.A., Thiene G., et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006; vol. 113: pp. 1807-1816.
29. Maron BJ and Fox PR. Hypertrophic cardiomyopathy in man and cats. J Vet Cardiol 2015; vol. 17S1: pp. 6-9.
30. Nelson L, Reidesel E, Ware WA, et al. Echocardiographic and radiographic changes associated with systemic hypertension in cats. J Vet Intern Med. 2002; vol. 16: pp. 418-425.
31. Novo Matos J, Pereira N, Glaus T, et al. Transient myocardial thickening in cats associated with heart failure. J Vet Intern Med. 2018; vol. 32: pp. 48-56.
32. Payne JR, Borgeat K, Brodbelt DC, et al. Risk factors associated with sudden death vs. congestive heart failure or arterial thromboembolism in cats with hypertrophic cardiomyopathy. J Vet Cardiol. 2015; vol. 17S1: pp. 318-328.
33. Payne JR, Borgeat K, Connolly DJ, et al. Prognostic indicators in cats with hypertrophic cardiomyopathy. J Vet Intern Med. 2013; vol. 27: pp. 1427-1436.
34. Payne JR, Brodbelt DC, Luis Fuentes V. Cardiomyopathy prevalence in 780 apparently healthy cats in rehoming centres (the CatScan study). J Vet Cardiol. 2015; vol. 17S1: pp. 244-257.
35. Romito G, Guglielmini C, Mazzarella MO, et al. Diagnostic and prognostic utility of surface electrocardiography in cats with left ventricular hypertrophy. J Vet Cardiol. 2018; vol. 20: pp. 364-375.
36. Schober KE and Chetboul V. Echocardiographic evaluation of left ventricular diastolic function in cats: hemodynamic determinants and pattern recognition. J Vet Cardiol. 2015; vol. 17S1: pp. 102-133.
37. Schober KE and Todd A. Echocardiographic assessment of left ventricular geometry and the mitral valve apparatus in cats with hypertrophic cardiomyopathy. J Vet Cardiol. 2010; vol. 12: pp. 1-16.
38. Schober KE, Savino SI, Yildiz V. Right ventricular involvement in feline hypertrophic cardiomyopathy. J Vet Cardiol. 2016; vol. 18: pp. 297-309.
39. Spalla I, Boswood A, Connolly DJ, et al. Speckle tracking echocardiography cats with preclinical hypertrophic cardiomyopathy. J Vet Intern Med. 2019; vol. 33: pp. 1232-1241.
40. Spalla I, Payne JR, Borgeat K, et al. Mitral Annular Plane Systolic Excursion and Tricuspid Annular Plane Systolic Excursion in Cats with Hypertrophic Cardiomyopathy. J Vet Intern Med. 2017; vol. 31: pp. 691-699.
41. Vezzosi T and Schober KE. Doppler-derived echocardiographic evidence of pulmonary hypertension in cats with left-sided congestive heart failure. J Vet Cardiol. 2019; vol. 23: pp. 58-68.
42. Visser LC, Sloan CQ, Stern JA. Echocardiographic Assessment of Right Ventricular Size and Function in Cats With Hypertrophic Cardiomyopathy. J Vet Intern Med. 2017; vol. 31: pp. 668-677.
TORNA INDIETRO
Patologia comparata del tumore alla prostata del cane e dell'uomo
Sebbene relativamente raro nei cani, il cancro alla prostata (PCa) è il tumore non cutaneo più comune negli uomini. Le ghiandole prostatiche umane e canine condividono molte caratteristiche funzionali, anatomiche e fisiologiche. A causa di queste somiglianze, il PCa canino è stato proposto come modello per il PCa negli uomini.
